2011
DOI: 10.1038/nrneph.2011.39
|View full text |Cite
|
Sign up to set email alerts
|

Donor risk scores: can they predict renal transplant outcomes?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Deceased donors are classified as ECD based on an algorithm that takes into account four characteristics: age, cause of death, history of hypertension, and renal dysfunction [2,3]. In order to grade the spectrum of ECD quality, different studies have explored the predictive value of histological versus clinical scoring systems [4,5,6]. The evaluation criteria of pre-implantation biopsies arise from a quantitative assessment of the lesions in different renal compartments, namely vascular intimal sclerosis, tubular atrophy, interstitial fibrosis, interstitial inflammation, mesangial matrix increase and glomerular sclerosis [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…Deceased donors are classified as ECD based on an algorithm that takes into account four characteristics: age, cause of death, history of hypertension, and renal dysfunction [2,3]. In order to grade the spectrum of ECD quality, different studies have explored the predictive value of histological versus clinical scoring systems [4,5,6]. The evaluation criteria of pre-implantation biopsies arise from a quantitative assessment of the lesions in different renal compartments, namely vascular intimal sclerosis, tubular atrophy, interstitial fibrosis, interstitial inflammation, mesangial matrix increase and glomerular sclerosis [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…Various tools to aid decision-making are currently available or under investigation. These include donor risk scores in the setting of DCD kidneys ( 85 ), donor-recipient characteristics ( 86 ), donor-specific features ( 87 ), monitoring of perfusion parameters and assessment of tissue viability function ex situ ( 88 ), molecular diagnostics ( 89 ), and machine learning and artificial intelligence (AI) algorithms ( 90 - 92 ). The latter remains in its infancy, with tremendous potential to augment the decision-making regarding transplantation ( 93 ), but requires more granular data, generalizability, and validation across different population cohorts to enter mainstream use.…”
Section: Decision Challengesmentioning
confidence: 99%